Aridis Pharmaceuticals In... (ARDS)
undefined
undefined%
At close: undefined
0.00
-99.00%
Pre-market Oct 07, 2024, 09:30 AM EDT

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY22 FY21 FY20 FY19 FY18 FY17 FY16
Net Income -30.37M -42.19M -22.33M -29.68M -22.11M -24.66M -8.42M
Depreciation & Amortization 487.00K 435.00K 337.00K 338.00K 283.00K 62.00K 23.00K
Stock-Based Compensation 1.48M 2.25M 2.13M 2.01M 1.66M 1.61M 858.00K
Other Working Capital 2.63M 7.86M -534.00K 19.58M -97.00K 120.00K 180.00K
Other Non-Cash Items 577.00K 6.78M 9.00K 951.00K -1.59M 5.15M 369.00K
Deferred Income Tax n/a -722.00K n/a n/a n/a n/a 172.00K
Change in Working Capital -1.30M 10.52M -617.00K 18.22M -2.52M 277.00K 909.00K
Operating Cash Flow -29.13M -22.94M -20.48M -8.16M -24.27M -17.56M -6.09M
Capital Expenditures -82.00K -530.00K -367.00K -174.00K -677.00K -698.00K -15.00K
Acquisitions n/a n/a n/a n/a -1.00M n/a n/a
Purchase of Investments n/a n/a n/a n/a -1.00M n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies n/a n/a n/a n/a 1.00M n/a n/a
Investing Cash Flow -82.00K -530.00K -367.00K -174.00K -1.68M -698.00K -15.00K
Debt Repayment 3.20M 5.00M 715.00K n/a n/a n/a -300.00K
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a -4.13M n/a n/a -1.36M n/a n/a
Other Financial Acitivies -1.03M 4.13M 14.00K 35.00K 1.37M 21.06M 25.80M
Financial Cash Flow 14.78M 34.72M 8.68M 4.99M 25.09M 21.06M 25.50M
Net Cash Flow -14.43M 11.25M -12.16M -3.34M -859.00K 2.81M 19.40M
Free Cash Flow -29.21M -23.47M -20.84M -8.33M -24.95M -18.25M -6.11M

Create Price Alert on ARDS

Your price alert will notify you when the stock price is above 0.00.

Add to Watchlist